Home

The Viridis (veer’-ih-diss) Group

Established in 2000, The Viridis Group is an innovative Vermont-based management consulting firm dedicated to emerging (i.e., small-to-midsize) biotechnology and biopharmaceutical companies, academic-based biomedical researchers and investment capital providers in the discovery, research, development and commercialization of new and novel technologies and products.

Industry News Feeds
Massachusetts Biotechnology Council
- An error has occurred, which probably means the feed is down. Try again later.
Organisation for Economic Cooperation and Development
BIOTech NOW
Patently BIOtech
- Translational Research Forum at BIO International Convention June 16, 2011
- University-Industry Partnering at BIO Convention Webinar by AUTM June 16, 3-4PM June 15, 2011
- BIO has issued a strong letter of support for the Manager’s Amendment to H.R. 1249, the America Invents Act June 15, 2011
Biotech Insider
- Opinions and the stuff that wastes my time August 21, 2005
- Interviewing Success in Biotech August 18, 2005
- The Stem Cell War (Fortune Magazine) August 17, 2005
NYT > Biotechnology
- Can Africa Get Close to Vaccine Independence? Here’s What It Will Take. April 25, 2023
- When the Horseshoe Crabs Are Gone, We’ll Be in Trouble February 17, 2023
- U.S.D.A. Approves First Vaccine for Honeybees January 10, 2023

Management consulting services directed to emerging biotechnology and biopharmaceutical companies, academic-based biomedical researchers and providers of investment capital (e.g., venture cap, angel investors).

Home

The Viridis (veer’-ih-diss) Group

Industry News Feeds

Massachusetts Biotechnology Council

Organisation for Economic Cooperation and Development

BIOTech NOW

Patently BIOtech

Biotech Insider

NYT > Biotechnology